Table 1. Clinical variables of melanoma patients from TCGA and GSE65904.
| Clinical variables | TCGA | % | GSE65904 | % |
|---|---|---|---|---|
| Total | 338 | 193 | ||
| Age | ||||
| <65 years | 215 | 63.61 | 99 | 51.30 |
| ≥65 years | 123 | 36.39 | 94 | 48.70 |
| Sex | ||||
| Male | 209 | 61.83 | 114 | 59.07 |
| Female | 129 | 38.17 | 79 | 40.93 |
| Stage | ||||
| I | 71 | 21.01 | – | – |
| II | 112 | 33.14 | – | – |
| III | 144 | 42.60 | – | – |
| IV | 11 | 3.25 | – | – |
| T classification | ||||
| T0 | 23 | 6.80 | – | – |
| T1 | 37 | 10.95 | – | – |
| T2 | 69 | 20.41 | – | – |
| T3 | 83 | 24.56 | – | – |
| T4 | 126 | 37.28 | – | – |
| M classification | ||||
| M0 | 327 | 96.75 | – | – |
| M1 | 11 | 3.25 | – | – |
| N classification | ||||
| N0 | 191 | 56.51 | – | – |
| N1 | 65 | 19.23 | – | – |
| N2 | 41 | 12.13 | – | – |
| N3 | 41 | 12.13 | – | – |
| Follow-up time | ||||
| <5 years | 221 | 65.38 | 170 | 88.08 |
| ≥5 years | 117 | 34.62 | 23 | 11.92 |
| Survival status | ||||
| Survival | 182 | 53.85 | 98 | 50.78 |
| Death | 156 | 46.15 | 95 | 49.22 |
TCGA, The Cancer Genome Atlas.